Scarica l'app Stockscreener
7.95
4.10%
-0.34
Dopo l'orario di chiusura:
7.94
-0.010
-0.13%
Precedente Chiudi:
$8.29
Aprire:
$8.4
Volume 24 ore:
104.56K
Relative Volume:
0.20
Capitalizzazione di mercato:
$29.02M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+9.20%
1M Prestazione:
-11.96%
6M Prestazione:
-11.37%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$7.88
$8.6099
Intervallo di 1 settimana:
$6.855
$8.6099
Portata 52W:
$4.06
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Nome
Traws Pharma Inc
Settore
Industria
Telefono
267-759-3680
Indirizzo
12 PENNS TRAIL, NEWTOWN
Confronta TRAW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
7.95 | 29.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-01 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-05-18 | Iniziato | Guggenheim | Buy |
| 2018-03-01 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-17 | Downgrade | Maxim Group | Buy → Hold |
| 2017-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2017-04-27 | Iniziato | Laidlaw | Buy |
| 2015-07-01 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Traws Pharma Inc Borsa (TRAW) Ultime notizie
Traws Pharma Names Nora Brennan Interim CFO -February 07, 2025 at 04:43 pm EST - Marketscreener.com
Orbimed Advisors LLC Expands Stake in Traws Pharma Inc - GuruFocus.com
Traws Pharma Advances Bird Flu Treatment with Successful Phase I Trial - MSN
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug - Yahoo Finance
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu - Marketscreener.com
Traws Pharma's Bird Flu Drug Shows Promise in Phase I Safety Trial, Targets H5N1 Prevention - StockTitan
Traws Pharma, Expert Systems: Breakthrough in H5N1Bird Flu antiviral program - MSN
Traws Pharma Shares Surge 57% in After-Hours Trading Following Antiviral Trial Update - Yahoo Finance
Traws Pharma (TRAW) Stock Skyrockets In After-Hour Trading - Stocks Telegraph
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program - The Malaysian Reserve
Traws stock rallies 24% on avian flu drug update - MSN
Expert Systems And Traws Pharma Report Breakthrough In H5n1bird Flu Antiviral Program - MENAFN.COM
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Traws Phar - GuruFocus.com
Traws Pharma Secures $72.6 Million for Bird Flu Treatment Development - MSN
SEC Form 424B4 filed by Traws Pharma Inc. - Quantisnow
Traws Pharma secures up to $72.6 million in funding By Investing.com - Investing.com Canada
Traws stock plunges 43% on financing update - MSN
Traws Pharma, Inc. announced that it expects to receive $72.6 million in funding - Marketscreener.com
Is Traws Pharma Inc (NASDAQ: TRAW) Doomed From The Get-Go? - Stocks Register
Bucks County firm's shares plunge on capital raise plan - The Business Journals
Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha
Crude Oil Gains 1%; Chicago PMI Falls In December - Benzinga
Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn
Dismal Market Sentiment Pushes VIX Higher - Schaeffers Research
Traws Pharma Secures $72.6 Million in Financing to Advance Bird Flu Treatment Development - Tandav Media
Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn
Stock market news: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn
Traws Pharma secures up to $72.6 million in funding - Investing.com India
Traws Pharma announces $72.6M financing - TipRanks
Traws Pharma Secures $72.6M Financing for Bird Flu Drug Development from Leading Healthcare Investors - StockTitan
Single Peoples' Personalities Differ from Partnered Peoples' - 69News WFMZ-TV
Traws Pharma stock soars 200% on encouraging bird flu drug data - MSN
Traws Pharma soars as it advances H5N1 bird flu treatment - The Pharma Letter
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Traws Pharma, Inc. Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu - Marketscreener.com
Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November - Benzinga
Traws Pharma (TRAW) Shares Jump On Strong Trial Results - Stocks Telegraph
Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results - Benzinga
Traws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest Soars - MSN
Stock market news: Direct Digital Holdings +405.45%, Reliance Global Group +214.17% among top gainers during mid day trading - Business Upturn
Stock market news: Direct Digital Holdings up by 363.64% while iLearningEngines down by 70.88% during mid day trading - Business Upturn
Key pre-market developments in biotech & aerospace - RagingBull
Stock market today: Traws Pharma +231.47%, Rumble +59.02% among top gainers in early trading - Business Upturn
US Stocks Mixed, Dow Tumbles 150 Points - Benzinga
Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn
Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment - MarketWatch
Traws Pharma advances bird flu treatment candidate - Investing.com
Traws Pharma's Bird Flu Drug Shows Breakthrough Results in Phase 1 Trial, Achieves 23-Day Protection - StockTitan
The Most Therapeutic Kind of Me-Time - 69News WFMZ-TV
Traws Pharma announces board member departure By Investing.com - Investing.com Australia
Traws Pharma Inc Azioni (TRAW) Dati Finanziari
Non sono disponibili dati finanziari per Traws Pharma Inc (TRAW). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):